Gastrodin against oxidative stress-inflammation crosstalk via inhibiting mtDNA/TLR9 and JAK2/STAT3 signaling to ameliorate ischemic stroke injury
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.113012 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Menglian Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230011, China. Hauptthemen laut MEDLINE: Benzyl Alcohols, Glucosides, Janus Kinase 2, STAT3 Transcription Factor. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
The pathway of Janus-activated kinase 2 (JAK2) and signal transducer and activator of transcription 3 (STAT3) (termed as JAK2/STAT3) plays an active role in stroke-related inflammation induced by ischemic stress. Gastrodin, the primary compound in Gastrodia elata Bl, has been identified for its notable neuroprotective effects and demonstrated to ameliorate cerebral ischemia-reperfusion but its exact mechanisms governing this defense are still unclear. This study aims to investigate whether gastrodin can regulate mitochondrial function via the JAK2/STAT3 pathway to limit cerebral ischemia-reperfusion. In vivo, gastrodin significantly reduced infarct volume, improved neurobiological function, attenuated neuronal apoptosis, oxidative stress, mitochondrial impairment, mtDNA leakage, and inflammatory responses. At the cellular level, gastrodin administration rescued OGD/R-induced cell apoptosis, oxidative stress, and mitochondrial dysfunction. Mechanistically, gastrodin notably suppressed Toll-like receptor 9 (TLR9) expression, important for the recognition of disrupted endogenous DNA to produce inflammatory reactions. Furthermore, gastrodin mitigated inflammation by inhibiting JAK2/STAT3 signaling, influencing inflammatory factors to aggravate inflammation. Notably, the effects of gastrodin were abolished by Coumermycin A1 (C-A1), a JAK2 agonist, validating the role of JAK2/STAT3 signaling. In summary, gastrodin enhances the protective effect against mitochondrial damage in ischemic stroke by inhibiting JAK2/STAT3 signaling. Gastrodin is a possible therapy for cerebral ischemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230011, China.
- State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China.
- School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230011, China. Electronic address: hanlan56@ahtcm.edu.cn.
- School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230011, China; State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China; Institute for the…
Zitieren
APA
Zhang, M., Zhang, Y., Peng, J., Huang, Y., Gong, Z., Lu, H., Han, L., & Wang, D. (2024). Gastrodin against oxidative stress-inflammation crosstalk via inhibiting mtDNA/TLR9 and JAK2/STAT3 signaling to ameliorate ischemic stroke injury. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113012
Vancouver
Zhang M, Zhang Y, Peng J, Huang Y, Gong Z, Lu H, et al. Gastrodin against oxidative stress-inflammation crosstalk via inhibiting mtDNA/TLR9 and JAK2/STAT3 signaling to ameliorate ischemic stroke injury. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113012
BibTeX
@article{Zhang2024,
author = {Zhang, Menglian and Zhang, Yaowen and Peng, Jinyong and Huang, Yingying and Gong, Zipeng and Lu, Huixin and Han, Lan and Wang, Dandan},
title = {Gastrodin against oxidative stress-inflammation crosstalk via inhibiting mtDNA/TLR9 and JAK2/STAT3 signaling to ameliorate ischemic stroke injury},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.113012}
}
EUVIMED